LeBron James and Tonal
The NBA superstar isn’t just cashing endorsement checks.
In May 2019, a class-action lawsuit was filed against Boehringer Ingelheim Pharmaceuticals for allegedly deceptively marketing that the Combivent Respimat asthma inhaler will provide 120 doses when, according to plaintiffs, the inhaler contains far fewer dosages, sometimes less than half the advertised amount. (Ignacuinos et al v. Boehringer Ingelheim Pharmaceuticals, Inc., Case No. 19-cv-672, D. Conn.)
The NBA superstar isn’t just cashing endorsement checks.
Lawsuit alleges environmental claims don’t stick.
Got milk? Apparently not.
Flag on the play.
What you need to know about what some are calling “liquid gold.”